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Abstract
 
Mycobacterium tuberculosis
 
 residing within pulmonary granulomas and cavities represents an im-
portant reservoir of persistent organisms during human latent tuberculosis infection. We present
a novel in vivo model of tuberculosis involving the encapsulation of bacilli in semidiffusible hollow
fibers that are implanted subcutaneously into mice. Granulomatous lesions develop around these
hollow fibers, and in this microenvironment, the organisms demonstrate an altered physiologic
state characterized by stationary-state colony-forming unit counts and decreased metabolic activity.
Moreover, these organisms show an antimicrobial susceptibility pattern similar to persistent bacilli
in current models of tuberculosis chemotherapy in that they are more susceptible to the steriliz-
ing drug, rifampin, than to the bactericidal drug isoniazid. We used this model of extracellular
persistence within host granulomas to study both gene expression patterns and mutant survival
patterns. Our results demonstrate induction of 
 
dosR
 
 (
 
Rv3133c
 
) and 20 other members of the
DosR regulon believed to mediate the transition into dormancy, and that 
 
rel
 
Mtb
 
 is required for
 
Mycobacterium tuberculosis
 
 survival during extracellular persistence within host granulomas. Inter-
estingly, the dormancy phenotype of extracellular 
 
M. tuberculosis
 
 within host granulomas appears
to be immune mediated and interferon-
 
 
 
 dependent.
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Introduction
 
Mycobacterium tuberculosis
 
 infects approximately one third of
the world’s population, resulting in three million deaths
annually (1). Soon after inhalation of tubercle bacilli, the
organisms are phagocytosed by alveolar macrophages, resulting
in potent cell-mediated immune responses and the formation
of granulomas, which consist primarily of T cells and 
 
M.
tuberculosis
 
–infected macrophages (2, 3). 6–8 wk after infec-
tion in humans, and coincident with the development of a
delayed-type hypersensitivity response manifested by tubercu-
lin skin test positivity, these granulomas undergo caseous
necrosis, resulting in the death of the majority of tubercle
bacilli and destruction of surrounding host tissue (4). The
small proportion of surviving bacilli are thought to exist in
a nonreplicating hypometabolic state, as an adaptation to
the unfavorable milieu in the solid caseous material (4).
This altered physiologic state, termed latent tuberculosis in-
fection, can endure for the lifetime of the infected individual,
but in 
 
 
 
10% of cases, through unknown mechanisms,
these dormant bacilli reactivate many years to decades later
to produce disease.
Efforts to gain insight into the adaptive mechanisms by
which 
 
M. tuberculosis
 
 persists in the host have been impeded
by the inability to recover sufficient quantities of 
 
M. tuber-
culosis
 
 RNA from host lesions consistent with contained
latent tuberculosis infection (5). Consequently, several groups
have turned to in vitro models that may reflect the per-
sistent state, and have defined the gene expression profile of
 
M. tuberculosis
 
 under conditions of hypoxia (6, 7), nutrient
starvation (8), low pH (9), low concentrations of nitric oxide
(10), and in the phagosomal compartment of murine mac-
rophages (11). Current work has focused on the role of the
two-component response regulator dormancy survival reg-
ulator (DosR), which initially was found to be the primary
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mediator of the hypoxic response in 
 
M. tuberculosis
 
 (6, 12).
Bacilli exposed to low, nontoxic concentrations of nitric
oxide in vitro enter a nonreplicating persistent state marked
by the induction of a 48-gene regulon under the control of
DosR, suggesting that the DosR regulon may mediate the
transition of these bacilli into dormancy (10). Consistent
with these findings, several DosR regulon genes, including
 
acr
 
 (
 
Rv2031c
 
), 
 
Rv2623c
 
, and 
 
Rv2626
 
, are up-regulated in in-
fected mouse tissues after the onset of Th1 immunity (10, 13).
We sought to mimic the caseous granuloma by physical
containment of extracellular 
 
M. tuberculosis
 
 within mice as a
means of comparing in vivo–cultivated persistent bacteria
with in vitro latency models. Our model involves the en-
capsulation of tubercle bacilli in polyvinylidene fluoride
(PVDF) hollow fibers (14, 15) and the implantation of
these fibers into the subcutaneous space of mice (see Fig.
1). The PVDF fibers have a molecular mass cutoff of 500
kD, which allows for the diffusion of small soluble mole-
cules, but prevents the entry of host immune cells and the
exit of intact bacilli. The prevention of direct host–patho-
gen interactions imposed by the physical properties of the
hollow fibers provides a unique opportunity to study the
behavior of extracellular 
 
M. tuberculosis
 
 in the host.
 
Materials and Methods
 
Strains. M.  tuberculosis
 
 H37Rv-expressing firefly luciferase
(H37Rv-
 
lux
 
) was passaged twice through mice and used for all
infections. The organisms were grown in plastic roller bottles at
37
 
 
 
C in Middlebrook 7H9 liquid broth (Difco Laboratories) sup-
plemented with 10% OADC (Becton Dickinson), 0.5% glycerol,
and 0.05% Tween-80.
 
Hollow Fiber Assay. 
 
Infection with 
 
M. tuberculosis
 
 was achieved
in 6–8-wk-old female hairless, immunocompetent SKH1 mice
(Charles River Laboratories) using the hollow fiber encapsulation/
implantation technique as described previously (14, 15). In brief,
liquid cultures of 
 
M. tuberculosis
 
 were inoculated into the lumen
of PVDF hollow fibers (molecular mass cutoff 500 kD; Spectrum
Laboratories) with a syringe and 20-gauge needle. The ends of
the hollow fibers were heat sealed, and individual fibers were
prepared by heat sealing at 2-cm intervals. Mice were anesthetized
by intraperitoneal injection of 240 mg/kg of Avertin (2,2,2-tribro-
moethanol; Sigma-Aldrich), and the dorsal skin surface was steril-
ized with 70% ethanol. A small incision was made at the nape of
the neck, and one fiber was deposited into the subcutaneous space
of each flank with a tumor trocar (two fibers/mouse). Incisions
were closed with a small surgical clip (Fig. 1). For immunology
studies, BALB-C/J and IFN
 
 
 
   
 
 (B6-IFNg
 
tmITSIJ
 
) mice were used
(Jackson ImmunoResearch Laboratories). For experiments involv-
ing hollow fiber–encapsulated 
 
M. tuberculosis
 
 incubated in vitro,
hollow fibers were incubated on a shaker at 37
 
 
 
C in 50-ml conical
tubes containing 20 ml Middlebrook 7H9 liquid broth (Difco Lab-
oratories) supplemented with 10% OADC (Becton Dickinson),
0.5% glycerol, and 0.05% Tween-80. For determination of CFU
counts, hollow fibers were recovered from mice at the time of kill-
ing, and their contents were plated on 7H10 agar plates (Fischer
Scientific). Log-transformed CFU values were used to calculate
averages and standard errors for graphing purposes.
 
Luciferase Assay. 
 
The luciferase reaction was initiated by the
addition of 150 
 
 
 
l of luciferin (1 mM in 0.1 M Na citrate;
Promega) to 50 
 
 
 
l of each undiluted sample. Luminescence was
detected 20 s after the addition of substrate by a TD-20/20 lumi-
nometer (Turner Designs). Three successive measurements were
made and the average relative light unit (RLU) values recorded.
The log
 
10
 
 of average RLU values multiplied by 1,000 was repre-
sented graphically.
 
Microarrays. 
 
Hollow fibers each containing 10
 
6
 
 bacilli were
implanted into 15–20 SKH1 mice (two hollow fibers/mouse).
Hollow fibers were retrieved from mice 10 d after hollow fiber
encapsulation, and fiber contents were recovered and snap frozen.
Pooled samples were suspended in TRIzol reagent (GIBCO
BRL), and 
 
M. tuberculosis
 
 membranes were disrupted using zirco-
nia/silica beads in a bead beater. 
 
M. tuberculosis
 
 RNA was recov-
ered by centrifugation, chloroform extraction, and isopropyl alco-
hol precipitation, and purified using RNeasy column (QIAGEN)
as described previously (6, 8). The same steps were followed to
extract and purify RNA from mid-logarithmic phase (
 
A
 
600
 
,
0.600–0.850) 
 
M. tuberculosis
 
 H37Rv-
 
lux
 
 cultures grown in plastic
roller bottles at 37
 
 
 
C in supplemented liquid broth. Fluorescently
labeled cDNA was generated using Powerscript (CLONTECH
Laboratories, Inc.), using fluorescent dyes Cy3 and Cy5. These
cDNA were competitively hybridized on microarray slides con-
taining commercially available (Operon) 
 
M. tuberculosis
 
 70-mer
oligonucleotides representing all opening reading frames anno-
tated in the H37Rv genome sequencing project (16), and fluores-
cence intensity data were collected with a GenePix 4000 scanner
(Axon Instruments, Inc.) with Pro 4.0 software. Data were nor-
malized based on total intensity of good-quality spots above back-
ground for each channel, and ratios of in vivo hollow fiber to in
vitro cDNA were calculated based on normalized data. In this as-
say, the ratio of the signal from in vivo hollow fiber samples to
that of in vitro control samples for a given open reading frame
(ORF) should represent the relative abundance of the transcripts
of that ORF under the two conditions. Three biological replicates
were performed, and microarray samples were reverse labeled in
one experiment. Significant differential regulation of genes was
defined by greater than or equal to twofold change in gene ex-
pression as compared with control samples and P 
 
 
 
 0.01.
 
Quantitative Real-Time RT-PCR. 
 
RNA samples were treated
with DNA-free kit (Ambion) according to the instructions of
the  manufacturer, and DNA contamination was excluded by
PCR amplification using primers for 
 
Rv2031
 
 (
 
acr
 
) and absence of
PCR product on gel electrophoresis (unpublished data). Reverse
transcription of RNA samples (
 
 
 
0.5 
 
 
 
g RNA/sample) was
accomplished using random hexamer primers (0.5 
 
 
 
g/reaction;
Figure 1. SKH1 mouse with subcutaneously implanted hollow fiber
containing M. tuberculosis. 
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Invitrogen) and Powerscript Reverse Transcriptase (CLON-
TECH Laboratories, Inc.). Real-time PCR was performed on
cDNA using the SYBR green assay and Premix D (Epicentre) for
all samples, and fluorescence was measured by iCycler (Bio-Rad
Laboratories). Gene expression was compared with that of 
 
sigA
 
,
an 
 
M. tuberculosis
 
 housekeeping gene.
 
Transposon (Tn) Mutants. 
 
Random insertion mutagenesis of
 
M. tuberculosis
 
 CDC 1551 strain was performed using the 
 
Himar1
 
Tn as described previously (17, 18). Tn insertion sites were iden-
tified by sequencing the insertion junction as described previously
(18). 100 different mutants, each with Tn insertion within the
proximal 80% or proximal to the distal 100 base pairs of the
ORF, were randomly selected from the library of mutants. Each
of the selected mutants was separately grown in 37
 
 
 
C in supple-
mented Middlebrook 7H9 liquid broth to an 
 
A
 
600
 
 of 0.8–1.0, and
two master pools, each consisting of 50 mutants, were prepared
by mixing an equal volume of culture of each mutant. This mix-
ture was diluted to an 
 
A
 
600
 
 of 0.1, and the latter was used to inoc-
ulate the hollow fibers. In separate experiments, the 
 
rel
 
Mtb
 
-dis-
rupted Tn insertion mutant was grown separately in vitro using
the aforementioned conditions to an 
 
A
 
600
 
 of 
 
 
 
1.0, and diluted
1:10. The diluted culture was added in a 1:1 ratio to a similarly
grown and diluted culture of wild-type CDC 1551. The 
 
 
 
rel
 
Mtb
 
/
wild-type culture suspension was encapsulated in hollow fibers as
described before and either implanted subcutaneously into mice
or incubated in vitro. Recovered hollow fiber samples were
plated on Middlebrook 7H10 plates (Difco Laboratories) and on
7H10 plates containing 20 
 
 
 
g/ml kanamycin (the Tn insertion
contains a kanamycin resistance gene; reference 18).
 
Viability Assay. 
 
The LIVE/DEAD 
 
Bac
 
Light Bacterial Viabil-
ity Kit (Molecular Probes) was used to assay for mycobacterial vi-
ability after removal from hollow fibers. In brief, component A
(3.34 mM SYTO 9 green fluorescent nucleic acid stain) and
component B (20 mM propidium iodide) were mixed in equal
volumes. An equivalent of 3 
 
 
 
l of this 1:1 nucleic acid stain mix-
ture was added to each 1 ml of sample, and samples were incu-
bated in the dark for 
 
 
 
15 min. As a control, in vitro–grown 
 
M.
tuberculosis
 
 H37Rv-
 
lux
 
 was treated for 3 h with 70% ethanol to
promote mycobacterial death and highlight differences in fluores-
cence staining between live and dead bacilli (see Fig. 3 a). Sam-
ples were treated with 20 
 
 
 
l of 4% paraformaldehyde (which
does not alter cell permeability characteristics) for 
 
 
 
15 min, and
samples were observed using epifluorescence microscopy (Nikon
Eclipse E800). Images were obtained using a Nikon digital cam-
era DXM1200 and processed using Spot Version 3.4 software.
 
Antibiotic Studies. 
 
Mice received a powdered diet containing
1% sugar with either 0.02% (by weight) rifampin (Sigma-Aldrich)
or 0.05% isoniazid (Sigma-Aldrich), beginning 14 d after implan-
tation of hollow fibers. Untreated control mice received pow-
dered diet containing 1% powdered sugar alone. In separate ex-
periments, mice received diet containing 2.5% sugar alone
(untreated controls) or with 0.25% moxifloxacin beginning on
day 1 after hollow fiber implantation. Mouse dietary consump-
tion was measured and recorded for all groups on a daily basis. At
the time of killing, blood was obtained from antibiotic-treated
mice by cardiac puncture, mouse serum was separated, and serum
samples were stored at 
 
 
 
70
 
 
 
C until the time of analysis. Mouse
serum samples were mailed overnight on dry ice to C. Peloquin
(National Jewish Medical Research Center, Denver, CO) for de-
termination of serum antibiotic concentrations.
 
Online Supplemental Material. 
 
A complete list of all Tn mu-
tants used, including information on the gene mutated and the
exact coordinate of Tn insertion, is presented as online supple-
mental material. DosR genes that fulfilled one, but not both, cri-
teria for significant up-regulation (see Results) are presented in
the online supplemental material. The complete lists of genes
found to be significantly up-regulated or down-regulated by mi-
croarray analysis in hollow fiber–encapsulated bacilli in vivo, as
well as all genes not found to be differentially regulated, are also
presented. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20040646/DC1.
 
Results
 
Inhibition of Growth of Encapsulated Tubercle Bacilli In Vivo
(Fig. 2). M.  tuberculosis
 
 H37Rv-expressing firefly lucif-
erase (H37Rv-
 
lux
 
) was encapsulated in hollow fibers and
implanted into the subcutaneous space of mice or incu-
bated at 37
 
 
 
C in supplemented Middlebrook 7H9 broth.
Although hollow fiber–encapsulated bacilli incubated in
vitro multiply exponentially for 14–21 d before reaching a
plateau, bacilli encapsulated in hollow fibers and implanted
into mice rapidly achieve stationary-state CFU counts (Fig.
2). The continued growth of in vitro hollow fiber–encap-
sulated bacilli implies that the failure of in vivo hollow fi-
ber–encapsulated bacilli to multiply is not simply a result of
physical containment imposed by the internal dimensions
of the hollow fibers.
 
Assessment of Bacillary Viability and Metabolic Activity.
 
To further investigate the CFU equilibrium in hollow fiber–
encapsulated bacilli in vivo, we examined the bacilli recov-
ered from fibers using a bacterial viability assay in which live
 
M. tuberculosis
 
 bacilli emit green fluorescence, whereas dead
bacilli fluoresce red, based on differences in cell membrane
permeability to the two nucleic acid stains used in the assay
(Fig. 3). If the stationary-state CFU counts observed in hol-
low fiber–encapsulated bacilli in vivo represented an equilib-
rium between bacillary multiplication and death, one would
expect that live-staining bacilli would comprise a very small
proportion of all staining bacilli, due to the vast accumula-
tion of dead bacilli over time. However, approximately half
of all staining organisms on days 21 (Fig. 3 b) and 28 (Fig. 3
c) after hollow fiber implantation were determined to be
alive by their staining properties, consistent with the hy-
pothesis that these organisms are in a slowly replicating or
Figure 2. Reduced growth of bacilli within hollow fibers in vivo. CFU
counts per fiber of hollow fiber–encapsulated M. tuberculosis implanted into
mice (HF in vivo) are compared with those of hollow fiber–encapsulated
M. tuberculosis incubated in vitro (HF in vitro). 
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nonreplicating persistent state. In addition, we detected a
significant lag time in the appearance of colonies after plating
the in vivo–cultivated bacilli, as compared with hollow fi-
ber–encapsulated bacilli incubated in vitro. At the day 21
time point, microcolonies were detected 10–11 d after plat-
ing in the in vitro hollow fiber samples, whereas these were
not detectable in the in vivo hollow fiber samples until 14 d
after plating (unpublished data). Furthermore, average col-
ony size for in vivo hollow fiber samples was significantly
smaller than corresponding in vitro hollow fiber samples
when examined 17 d after plating (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20040646/DC1). These
data are consistent with the hypothesis that hollow fiber–
encapsulated 
 
M. tuberculosis
 
 implanted in mice rapidly enter a
state of decreased replication.
Because the oxidation of luciferin to oxyluciferin and
photons (which can be detected by a luminometer at 
 
 
 
560
nm) is an ATP-dependent process, the luciferase assay may
be used as an indirect measure of the ATP content of cells.
In log-phase in vitro cultures of 
 
M. tuberculosis
 
 (i.e., not en-
capsulated in fibers), the relationship between CFUs and
RLUs is linear (Fig. 4 a). Hollow fiber-encapsulated 
 
M. tu-
berculosis
 
 grown in vitro maintains baseline metabolic activ-
ity, as reflected by RLU values that closely parallel CFU
counts at the corresponding time points (Fig. 4 b). On the
contrary, RLU values of in vivo–cultivated hollow fiber–
encapsulated bacilli on days 14 and 21 after implantation
(Fig. 4 b) were 0.8 log
 
10
 
 and 0.93 log
 
10
 
, respectively, less
than predicted based on the corresponding CFU values
(Fig. 2) and the proportionality of CFU:RLU (Fig. 4 a),
suggesting reduced metabolic activity of these organisms as
measured by the luciferase assay. These data suggest that in
vivo hollow fiber–encapsulated 
 
M. tuberculosis
 
 bacilli rapidly
enter a state of decreased metabolic activity.
 
Antibiotic Susceptibility of Hollow Fiber–encapsulated Bacilli.
 
Animal and human chemotherapy studies have pointed to
several populations of 
 
M. tuberculosis
 
 in the mammalian host,
including rapidly multiplying and nonreplicating or sporadi-
cally replicating persistent bacilli (19, 20). In keeping with
this mixed bacterial population model, drug treatment stud-
ies have demonstrated that the sterilizing drug rifampin
is more active against sporadically multiplying and persis-
tent bacilli than the bactericidal drug isoniazid; the former
drug requires a significantly shorter duration of therapy to
achieve acceptable relapse rates (21–25). We reasoned that
rifampin likewise should be more effective than isoniazid
against hollow fiber–encapsulated 
 
M. tuberculosis
 
 implanted
in mice if these bacilli were truly in a slowly replicating,
metabolically quiescent state. To allow bacilli to enter this
altered physiologic state, antibiotics were not initiated until
14 d after hollow fiber implantation. Experimental groups
of mice received either powdered diet containing isoniazid
0.05% or rifampin 0.02% (by weight), whereas untreated
mice received antibiotic-free diet. Serum concentrations of
each antibiotic were measured in killed mice at each time
point, and were found to be at least 10 times greater than
their respective MIC
 
90 (Table I). Daily area under the serum
concentration–time curve properties of each dietary regi-
men in mice were found to be similar to the area under the
serum concentration–time curve in humans after standard
daily doses of each drug (26, 27). Although isoniazid was
somewhat effective against bacilli in the hollow fiber model
in vivo, the activity of rifampin was more consistent and the
magnitude of its effect was greater than that of isoniazid at
each time point, resulting in a three-log kill by 21 d after
Figure 3. Hollow fiber–encapsulated bacilli in vivo remain viable. As a
control, in vitro–grown cultures of M. tuberculosis H37Rv-lux were
treated with 70% ethanol for 3 h to promote bacillary death (a). Live bacilli
exhibit green fluorescence, whereas dead bacilli fluoresce red. Approxi-
mately half of all in vivo hollow fiber–encapsulated organisms on days 21
(b) and 28 (c) after fiber implantation were determined to be viable based
on their staining properties.
Figure 4. Reduced metabolic ac-
tivity of encapsulated bacilli in vivo.
(a) Relationship of relative light
units (RLUs) to CFUs in mid-log
phase  M. tuberculosis H37Rv-lux
grown in vitro. (b) Luciferase activ-
ity of hollow fiber–encapsulated M.
tuberculosis implanted into mice (HF
in vivo) versus hollow fiber–encap-
sulated  M. tuberculosis incubated in
vitro (HF in vitro).Karakousis et al. 651
initiation of therapy (Fig. 5). When mice were treated with
the new 8-methoxyfluoroquinolone moxifloxacin, which
has potent bactericidal activity against M. tuberculosis in mice
(28), beginning on day 1 after hollow fiber implantation, fi-
bers were culture negative by day 14 after daily therapy
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20040646/DC1). These data suggest that by 14 d after
hollow fiber implantation, hollow fiber–encapsulated M. tu-
berculosis has entered an altered physiologic state in which
bacilli are more resistant to the activity of antituberculosis
drugs, but more susceptible to rifampin than to isoniazid,
consistent with the antibiotic susceptibility of persistent ba-
cilli in human latent tuberculosis infection (21–25).
Granuloma Formation Surrounding Bacilli-containing Hollow
Fibers in Mice. Interestingly, we observed grossly the pro-
gressive formation of thick, granuloma-like lesions encasing
hollow fibers containing M. tuberculosis H37Rv-lux (Fig. 6,
d–f), but not those containing liquid broth alone (Fig. 6,
a–c). By day 28 after hollow fiber implantation, histologic
analysis revealed much greater cellular infiltration of mac-
rophages, lymphocytes, and fibroblasts in the tissues sur-
rounding hollow fibers containing tubercle bacilli (Fig. 6 l),
as compared with those containing liquid broth (Fig. 6 i).
Acid-fast staining of the surrounding tissue revealed no de-
tectable bacilli, and inflammatory cells were not detected
by microscopy within the hollow fibers (unpublished data).
These results suggest the possibility that M. tuberculosis se-
cretes soluble factors that diffuse from the fibers, leading to
recruitment of host inflammatory cells. The formation of
granulomatous lesions encasing hollow fibers may create a
hostile microenvironment in which bacilli are forced to re-
duce their replication and metabolic activity, consequently
becoming more susceptible to rifampin than to isoniazid.
Containment of Intrafiber Bacillary Growth In Vivo Is Im-
mune Mediated and IFN  Dependent. In addition to local
granuloma formation, we detected significant spleen en-
largement as early as 14 d after hollow fiber implantation in
mice that had implanted fibers containing M. tuberculosis as
compared with those that had implanted fibers containing
media (Fig. 7 a), suggesting a systemic immune response in
the former group of mice. To further investigate the phe-
nomena of granuloma formation and splenomegaly and to
exclude the possibility that intrafiber bacillary growth con-
tainment in vivo is mediated exclusively by nutrient starva-
tion, we studied the growth of hollow fiber–encapsulated
M. tuberculosis in IFN -deficient mice. In brief,  500
bacilli were encapsulated in each hollow fiber, and fi-
bers were implanted subcutaneously either into wild-type
BALB-C/J mice or BALB-C/J IFN -deficient mice, and
colony counts were measured 28 d after implantation. In-
terestingly, although there was some growth of bacilli in
wild-type mice over 28 d, CFU counts of hollow fiber–
encapsulated M. tuberculosis in IFN -deficient mice were
1.3 log10 higher at 28 d than those in wild-type mice, sug-
Figure 5. Hollow fiber–encapsulated bacilli are
more susceptible to rifampin than to isoniazid. The ac-
tivities of isoniazid 0.05% in the diet (INH) and
rifampin 0.02% in the diet (RIF) against hollow fiber–
encapsulated bacilli in vivo are compared with no
treatment (Control).
Table I.  Serum Isoniazid and Rifampin Concentrations in Mice
SKH1 mice Humans
Dose Cmean AUC Dose Cmean AUC
% diet mg/L mg   h/L mg/kg mg/L mg   h/L
Isoniazid 0.02 0.77   0.21 18.5   5.0 5 5.4   2.0a, 7.1   1.9b 19.9   6.1a, 48.2   1.5b
Rifampin 0.05 3.09   0.41 74.2   9.8 10 14.91 117.93
aRapid acetylators.
bSlow acetylators.Modeling Tuberculous Granulomas Using Implanted Hollow Fibers in Mice 652
gesting that IFN  plays a role in containment of intrafiber
bacillary growth in vivo (Fig. 7 b).
Reduced Survival of relMtb-deficient M. tuberculosis in Hollow
Fibers Implanted into Mice. As proof-of-principle to deter-
mine whether this model could predict genes essential for
extracellular persistence within granulomas, we generated a
library of mutants by Tn mutagenesis of M. tuberculosis CDC
1551 strain using the Himar1 Tn as described previously
(18). 100 genetically defined mutants, each deficient in a
specific gene (as defined by Tn insertion within the proxi-
mal 80% or proximal to the distal 100 base pairs of the ORF
of each particular gene; reference 18), were selected from
the library and divided into two master pools, each consist-
ing of 50 mutants (Tables S1 and S2, available at http://
www.jem.org/cgi/content/full/jem.20040646/DC1). Each
pool was generated by mixing an equal volume of pure cul-
ture from each mutant to ensure equal representation. Indi-
vidual pools were encapsulated into separate hollow fibers
and these were either implanted subcutaneously into mice
or incubated in vitro. Hollow fiber contents were recovered
on day 1 (input pool) and day 21 (output pool) after infec-
tion. PCR amplification of the junction sites between the
Tn and the adjacent chromosomal DNA in the pooled ge-
nomic DNA from recovered mutants were performed at
each time point to determine the presence or absence of
each mutant. Of the 100 mutants tested, only those contain-
ing a Tn insertion in gene MT2660 (Rv2583c, relMtb) were
present in the in vivo input pool, but absent in the in vivo
output pool (Fig. 8 b). In contrast, this Tn mutant was
readily detectable in both input and output pools in vitro
(Fig. 8 a). Mice were also infected intravenously with pools
representing the same 100 Tn mutants. In concordance
with findings from the hollow fiber model in vivo, only the
relMtb-deficient mutant was found to have significantly de-
creased survival 49 d after infection (unpublished data).
M. tuberculosis deficient in RelMtb, an enzyme responsible
for the synthesis and hydrolysis of hyperphosphorylated
guanine nucleotides involved in the stringent response, has
been shown to be significantly attenuated compared with
wild type in the tissues of mice 38 wk after aerosol infection
(29). We decided to specifically evaluate the growth pheno-
type of the relMtb Tn insertion mutant (relMtb::Tn), which car-
ries a kanamycin resistance marker, in the hollow fiber
model in vivo. To ensure that each strain was exposed to
identical microenvironment conditions, a 1:1 mixture of
relMtb::Tn and wild-type strain M. tuberculosis CDC 1551 was
encapsulated in hollow fibers and either incubated in liquid
broth in vitro or implanted subcutaneously in mice. 21 d
later, hollow fibers were recovered and their contents were
diluted and plated on antibiotic-free and kanamycin-con-
taining plates to assess CFU counts for each hollow fiber–
encapsulated strain. There was no growth defect of relMtb::
Tn when incubated in vitro, as both hollow fiber-encapsu-
lated wild-type and relMtb::Tn bacilli grew equally after 21 d
of incubation (Fig. 8 c). However, although hollow fiber–
Figure 7. Containment of intrafiber bacillary growth in vivo is immune
mediated and IFN  dependent. Mice implanted with hollow fibers con-
taining M. tuberculosis (HF   M. tb) developed enlarged spleens as mea-
sured by mean spleen weight (y axis) as early as 14 d after implantation as
compared with mice implanted with fibers containing media (HF control;
a). Wild-type BALB-C/J (WT) mice are able to contain the growth of
hollow fiber–encapsulated M. tuberculosis to a greater extent than isogenic
IFN -deficient (IFN    ) mice 28 d after hollow fiber implantation (b).
Figure 6. Formation of granuloma-like lesions surrounding M. tuberculosis–
containing hollow fibers. Gross skin lesions surrounding hollow fibers con-
taining liquid broth alone at days 1 (a), 14 (b), and 28 (c), and those con-
taining M. tuberculosis H37Rv-lux at days 1 (d), 14 (e), and 28 (f) after
hollow fiber implantation. Histopathology of tissues surrounding hollow
fibers containing liquid broth (g–i) and those containing M. tuberculosis
H37Rv-lux (j–l) 28 d after hollow fiber implantation (hematoxylin-eosin
stain). Arrows indicate hollow fiber membrane.Karakousis et al. 653
encapsulated wild-type bacilli implanted in mice demon-
strated reduced growth as compared with those incubated in
vitro after 21 d (growth  1.5 log for in vivo wild type ver-
sus  3 log10 for in vitro wild type), hollow fiber–encapsu-
lated relMtb::Tn showed markedly reduced survival as com-
pared with wild-type bacilli implanted in vivo (Fig. 8 d).
Table II. Significantly Up-Regulated DosR Regulon Genes in the Hollow Fiber Model In Vivo by Microarray Analysis
Rv no. Gene Protein function Fold up-regulation p-value
80 HP 2.9 0.0009
569 CHP 4.9 0.007
570 nrdZ ribonucleotide reductase cl. II 2 6.17E-07
572c HP 2.2 0.002
1733c CHP 3 0.004
1997 ctpF cation transport ATPase 13.2 0.007
2005c CHP-USPA motif 2.2 0.003
2030c CHP 7.8 3.30E-05
2031c hspX  -crystallin 25 0.009
2623 CHP-USPA motif 25.8 0.0002
2626c CHP 14.6 0.0001
2627c CHP 8 0.008
2628 HP 8.4 0.004
2631 HP 2.1 0.001
3126c HP 2.2 0.0001
3128c CHP 3.2 0.004
3130c CHP 15.4 0.0003
3131 CHP 11.4 0.0008
3132c sensor histidine kinase 4.8 0.001
3133c dosR 2-comp. response reg. 2.1 0.007
3134c CHP-USPA motif 7.1 0.007
CHP, conserved hypothetical protein; HP, hypothetical protein.
Figure 8. Absence of relMtb-
deficient mutant by PCR from a
pool of mutants after 21 d of culti-
vation within mouse granulomas.
PCR amplification of the Tn in-
sertion junction (see Online
Supplemental Material) reveals
presence of the relMtb::Tn mutant
in both input (day 1) and output
(day 21) pools in hollow fibers in-
cubated in vitro (a), but absence of
the mutant in the output pool (day
21) in mouse-implanted hollow
fibers (b), suggesting reduced sur-
vival of this mutant in vivo. 1,
Rv1347 (hypothetical transcrip-
tional regulator); 2, Rv0250 (mis-
cellaneous  oxidoreductase); 3,
Rv2583c (relMtb); 4, Rv1069 (pra).
Hollow fiber–encapsulated wild-
type  M. tuberculosis CDC 1551
(WT) and relMtb::Tn mutant
(RelMtb) grow equally when in-
cubated in hollow fibers in vitro
(c), but the latter strain demon-
strates significantly reduced sur-
vival when hollow fibers are im-
planted into mice (d).Modeling Tuberculous Granulomas Using Implanted Hollow Fibers in Mice 654
Significantly, the decreased survival of the relMtb-deficient
mutant became apparent as early as 21 d after hollow fiber
implantation, as compared with several months using the
standard murine aerosol infection model (29). We observed
no significant change in survival compared with wild type
in an M. tuberculosis mutant containing a Tn insertion in an
unrelated gene (MT2749, Rv2675), suggesting that the
presence of the Tn insertion alone does not confer a survival
disadvantage in the hollow fiber model in vivo.
Gene Expression of Extracellular M. tuberculosis within Gran-
ulomas in Mice. Next, we sought to gain insight into the
adaptive response of tubercle bacilli in granulomatous le-
sions in vivo by studying their global gene expression (for
complete gene expression profile, Table S6, available at
http://www.jem.org/cgi/content/full/jem.20040646/DC1).
Significantly, the exclusion of host cells and containment of
bacilli by the hollow fibers renders whole genome microar-
ray analysis feasible. Hollow fibers containing M. tuberculosis
were implanted subcutaneously into mice and retrieved 10
d later. Hollow fiber contents were recovered and immedi-
ately snap frozen, and bacilli from 30–40 implanted fibers
were pooled to yield sufficient RNA for analysis. Hollow fi-
ber–encapsulated M. tuberculosis gene expression was com-
pared with that of log-phase in vitro–grown M. tuberculosis.
Significant differential gene regulation was defined by both
of the following: (a) a greater than or equal to twofold
change in gene expression as compared with control sam-
ples, and (b) a p-value  0.01.
We found that in vivo hollow fiber–encapsulated M. tu-
berculosis demonstrates significant induction of  260 genes,
including several key regulatory genes (Table S4, available
at http://www.jem.org/cgi/content/full/jem.20040646/DC1).
Using the aforementioned strict criteria, we found sig-
nificant up-regulation of Rv3133c (dosR) and 20 other
members of the previously described DosR regulon (10),
including hspX, Rv2623c, and Rv2626 (Table II), suggest-
ing that the adaptive response of hollow fiber–encapsulated
M. tuberculosis in vivo is similar to that of bacilli exposed to
low concentrations of nitric oxide in vitro. The M. tubercu-
losis hspX gene encodes  -crystallin, a member of the small
heat shock protein family with chaperone activity (30),
which is powerfully induced under hypoxic conditions (6)
and in lung specimens obtained from patients with active
tuberculosis disease (31). Significantly increased expression
of hspX, Rv2623c, and Rv2626 has been shown by real-
time RT-PCR after the onset of Th1-mediated immunity
in the mouse model of tuberculosis (13) and in various
models of latency in vitro (6, 8, 10, 13). In addition, we
found up-regulation of 12 additional genes of the DosR
regulon that fulfilled one, but not both, aforementioned
criteria (Table S3, available at http://www.jem.org/cgi/
content/full/jem.20040646/DC1). Hollow fiber–encapsu-
lated M. tuberculosis in vivo also demonstrated significant
up-regulation of sigB, sigC, and sigH, which belong to a
family of alternative RNA polymerase   factors shown to
coordinate gene regulation in response to environmental
conditions in M. tuberculosis and other bacterial species (32,
33). We detected significant up-regulation of dnaE2, which
encodes a DNA polymerase in M. tuberculosis and in other
organisms, and which has been shown to be up-regulated
by several DNA-damaging agents and during infection of
mice, contributing to in vivo survival and the emergence of
drug resistance (34). In addition, hollow fiber–encapsulated
M. tuberculosis in mice demonstrated significant induction
of many other genes recently found to be up-regulated in
the multibacillary model of murine tuberculosis (5), includ-
ing Rv0967, Rv0970, Rv0978c (PE-PGRS 17), Rv0980c
(PE-PGRS 18), Rv0982 (mprB), and Rv0988.
Consistent with evidence that M. tuberculosis might switch
to C2 carbon sources such as fatty acids during in vivo per-
sistence (35), we detected significant up-regulation of sev-
eral genes encoding enzymes involved in lipid degradation,
including  fadD10 ( Rv0099),  fadD19 ( Rv3515c),  fadD34
(Rv0035), fadE1 (Rv0131c), fadE10 (Rv0873), and fadE24
(Rv3139). In addition, we found significantly increased ex-
pression of pckA (Rv0211), suggesting limited availability of
glucose within artificial granulomas in mice. De novo syn-
thesis of glucose-6-phosphate in mycobacteria is achieved
through the action of phosphoenolpyruvate carboxykinase
(pckA), which converts oxaloacetate to phosphoenolpyru-
vate, thus diverting carbon derived from  -oxidation of
fatty acids into gluconeogenesis (36). Increased gene expres-
sion of pckA has been reported in the mouse model of tu-
berculosis (31), and disruption of pckA in Mycobacterium bovis
produced attenuated strains in animal models of infection
(37, 38). In addition, we found a 1.5-fold induction of
Rv0467 (aceA) (P   0.004) that encodes isocitrate lyase, the
first enzyme of the glyoxylate cycle, which is strongly in-
duced in mouse lungs (31) and is required for long-term
persistence of M. tuberculosis in mice (35).
Table III. Confirmation of Differential Regulation of a Subset of 
Genes by Quantitative Real-Time RT-PCR
Rv. no. Gene Protein function Fold induction
1997 HP 32
2031c acr  -crystallin 294.1
2623 CHP-USPA motif 512
2626c CHP 68.6
2710 sigB RNA polymerase   factor 42.2
2744 35 kD Ag 4.3
3130c CHP 168.9
3131 CHP 274.3
3133c dosR 2-comp. response regulator 78.8
3223c sigH RNA polymerase   factor 17.1
3370c dnaE2 DNA polymerase III 9.8
3477 PE family protein  4.3
3648c cspA prob. cold shock protein  7
CHP, conserved hypothetical protein; HP, hypothetical protein.Karakousis et al. 655
Consistent with the hypothesis that hollow fiber–encap-
sulated bacilli in vivo display a reduced replication rate,
we observed significantly decreased expression of certain
genes encoding ribosomal RNA binding proteins, includ-
ing Rv0701 (rplC), Rv0703 (rplW), Rv0704 (rplB), Rv0706
(rplV), Rv0708 (rplP), Rv0710 (rplQ), and Rv0716 (rplE).
In agreement with our luciferase assay data suggesting that
these bacilli have decreased intracellular energy stores (Fig.
4 b), we found significant down-regulation of several genes
encoding components of ATP synthase, including Rv1304
(atpB), Rv1306 (atpF), Rv1308 (atpA), Rv1310 (atpD), and
Rv1311 (atpC). A complete list of significantly down-regu-
lated genes in hollow fiber–encapsulated M. tuberculosis im-
planted into mice can be found in Table S5 (available at
http://www.jem.org/cgi/content/full/jem.20040646/DC1).
Differential regulation of a subset of 13 genes identified by
microarray analysis was confirmed using quantitative real-
time RT-PCR (Table III).
Discussion
The hollow fiber encapsulation/implantation technique
provides a means to establish a paucibacillary infection with
M. tuberculosis in which the bacilli are readily recoverable
from infected animals for further analysis. In this model of
infection, the tubercle bacilli rapidly enter an altered physi-
ologic state characterized by stationary-state CFU counts
and decreased metabolic activity. These bacilli are more
susceptible to the antituberculous drug rifampin than they
are to isoniazid, consistent with the antibiotic susceptibility
profile of persistent bacilli in animal chemotherapy models
(21, 23) and in human latent tuberculosis infection (22, 24,
25). In addition, expression of relMtb, a gene that is essential
for long-term persistence in the mouse model of chronic
tuberculosis (29), is also necessary for short-term bacillary
persistence in the hollow fiber granuloma model in vivo,
suggesting a common adaptive strategy of M. tuberculosis in
these two models of infection.
In this work, we present for the first time the whole-
genome transcriptional profile of extracellular M. tuberculo-
sis within granulomas in mice. In vivo hollow fiber–encap-
sulated M. tuberculosis demonstrates significant induction of
several key regulatory genes, including Rv3133c (dosR), as
well as 20 other genes of the recently described DosR reg-
ulon (10); the   factor genes sigB, sigC, and sigH; the DNA
polymerase-encoding dnaE2; and many other genes that
were found to be significantly up-regulated in the mouse
model of pulmonary tuberculosis (5). Increased expression
of genes involved in lipid metabolism suggests depletion of
glucose and the importance of fatty acids as a primary car-
bon source for extracellular M. tuberculosis in artificial gran-
ulomas in mice, which corroborates previous data in the
mouse model of chronic tuberculosis (35). Consistent with
the hypothesis that these organisms demonstrate an altered
physiologic state characterized by reduced replication and
metabolism, we detected significant down-regulation of
genes encoding key ribosomal RNA binding proteins and
ATP synthase, respectively. A subset of 13 genes identified
by microarray analysis was confirmed to be significantly
differentially regulated by quantitative real-time RT-PCR.
The common transcriptional profile we observed lends fur-
ther support to the hypothesis that the altered physiologic
state of hollow fiber–encapsulated bacilli in vivo is similar
to that of persistent bacilli in other models of latency.
It is important to note that, although the artificial subcuta-
neous granulomas surrounding hollow fibers containing M.
tuberculosis resemble those formed in mouse lungs after aerosol
infection with the same pathogen, granulomas in mice differ
significantly from those in humans. In human infection, the
granuloma is composed of a central core of macrophages, in-
cluding multinucleated giant cells, surrounded by macro-
phages and lymphocytes, which include CD4 and CD8 T
cells, and B cells (39). Although individual components of
mouse granulomas are similar to those in humans, the archi-
tecture of the mouse granuloma is better characterized as a
loose collection of activated and epithelioid macrophages and
lymphocytic clusters (40). Unlike in human granulomas,
multinucleated giant cells are absent in mouse granulomas,
and necrosis and caseation are rarely observed (40). However,
despite structural differences between granulomas in mice and
humans, their function is likely to be similar, with respect to
containment of infection and creation of a localized environ-
ment for the immune response to kill organisms.
Animal models of tuberculosis have shown that M. tuber-
culosis is an intracellular pathogen, residing within host
macrophages (2). However, the precise location of persis-
tent bacilli during human latent tuberculosis infection re-
mains elusive. Specifically, autopsy data of persons who
died of nontuberculosis-related causes have demonstrated
that tubercle bacilli may be found outside lung granulomas,
in normal-appearing lung tissue (41), and in nonmacro-
phage cell types, including alveolar epithelial cells (42). In
addition, bacilli residing extracellularly in the caseous ma-
terial of lung granulomas and cavities may represent an
important reservoir of persistent organisms during human
latent tuberculosis infection (4). Mouse-implanted hollow
fibers containing M. tuberculosis induce splenomegaly and
the accumulation of host inflammatory cells, including
macrophages and lymphocytes, leading to the formation of
artificial granulomas around the fibers. The precise mi-
croenvironment conditions prevailing within subcutane-
ously implanted hollow fibers are unclear, but may include
hypoxia, nutrient starvation, and soluble immunologic fac-
tors (e.g., diffusible nitric oxide) secreted by surround-
ing host immune cells. Diminished ability to contain the
growth of hollow fiber–encapsulated M. tuberculosis by
IFN -deficient mice, as well as significant induction of the
DosR regulon by these bacilli suggests that diffusible nitric
oxide and/or hypoxia may contribute to the microenvi-
ronment experienced by intrafiber bacilli in vivo. The basis
for mouse spleen enlargement and recruitment of host im-
mune cells to the tissues surrounding the hollow fibers is
unknown, but may involve diffusion of M. tuberculosis–
secreted soluble factors across the hollow fiber membranes.Modeling Tuberculous Granulomas Using Implanted Hollow Fibers in Mice 656
Experiments designed to address these questions are cur-
rently underway.
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